Dynamic changes of Kisspeptin during controlled ovarian hyperstimulation (COH) in polycystic ovary syndrome patients and its correlation with COH outcomes - Scorecard - MDSpire

Dynamic changes of Kisspeptin during controlled ovarian hyperstimulation (COH) in polycystic ovary syndrome patients and its correlation with COH outcomes

  • By

  • Lu Han

  • Yiran Wang

  • Yueying Li

  • Xiaoyan Li

  • Jing Zhang

  • Yan Zhang

  • Mingfei Zhao

  • Haixia Chen

  • Huiying Zhang

  • Yingmei Wang

  • Fengxia Xue

  • Wenyan Tian

  • May 20, 2026

  • 0 min

Share

Clinical Scorecard: Variations in Kisspeptin Levels During Controlled Ovarian Hyperstimulation in Patients with Polycystic Ovary Syndrome and Their Relationship with Treatment Outcomes

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationInfertile women with PCOS undergoing IVF-ET treatment.
Care Setting

Key Highlights

  • Add specific metrics for ovarian response metrics.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Monitor Kisspeptin levels at defined intervals during COH.

      Risks

        Patient & Prescribing Data

        Detail how Kisspeptin levels can guide dosage adjustments.

        Clinical Best Practices

        • Recommend specific assays or methods for evaluating Kisspeptin levels.

        Related Resources & Content

        Original Source(s)

        Dynamic changes of Kisspeptin during controlled ovarian hyperstimulation (COH) in polycystic ovary syndrome patients and its correlation with COH outcomes

        • by Lu Han, Yiran Wang, Yueying Li, Xiaoyan Li, Jing Zhang, Yan Zhang, Mingfei Zhao, Haixia Chen, Huiying Zhang, Yingmei Wang, Fengxia Xue, Wenyan Tian

        • May 20, 2026

        Related Content

        Uterine morphology in normogonadotropic anovulation: a comparative study of polycystic ovary syndrome and hypothalamic-pituitary-ovarian dysfunction

        FCGBP Links Hormonal Imbalance and Hepatic Steatosis in PCOS–NAFLD Comorbidity: An Integrative Bioinformatics and Experimental Study

        A Case Report: Treatment, follow-up, and literature review of type A insulin resistance syndrome caused by a De Novo INSR c.3328G>C mutation